Literature DB >> 21792530

[Diabetes mellitus and cognitive decline].

Bernhard Iglseder1.   

Abstract

From large epidemiological studies, it has been demonstrated that diabetes mellitus is a risk factor for cognitive decline: Compared to healthy controls, patients with diabetes perform worse on cognitive tests, they experience a pronounced cognitive decline over time and have a higher incidence of dementia. Mechanisms contributing to cognitive decline include vascular damage, negative consequences of hypo- and hyperglycemia, and various dysfunctions in insulin action, summarized as insulin resistance. Possible targets for prevention and treatment of cognitive decline have attracted scientific attention.

Entities:  

Mesh:

Year:  2011        PMID: 21792530     DOI: 10.1007/s10354-011-0003-x

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  50 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.

Authors:  Wei Qiao Qiu; Marshal F Folstein
Journal:  Neurobiol Aging       Date:  2005-02-17       Impact factor: 4.673

Review 3.  Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies.

Authors:  T Cukierman; H C Gerstein; J D Williamson
Journal:  Diabetologia       Date:  2005-11-08       Impact factor: 10.122

4.  Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus.

Authors:  H van Praag; G Kempermann; F H Gage
Journal:  Nat Neurosci       Date:  1999-03       Impact factor: 24.884

Review 5.  [Diabetes and cardiovascular complications].

Authors:  Michael Resl; Martin Clodi
Journal:  Wien Med Wochenschr       Date:  2010-01

6.  Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin.

Authors:  Chih-Cheng Hsu; Mark L Wahlqvist; Meei-Shyuan Lee; Hsin-Ni Tsai
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Physical activity over the life course and its association with cognitive performance and impairment in old age.

Authors:  Laura E Middleton; Deborah E Barnes; Li-Yung Lui; Kristine Yaffe
Journal:  J Am Geriatr Soc       Date:  2010-06-30       Impact factor: 5.562

8.  Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus.

Authors:  Tony Valente; Alejandro Gella; Xavier Fernàndez-Busquets; Mercedes Unzeta; Nuria Durany
Journal:  Neurobiol Dis       Date:  2009-09-22       Impact factor: 5.996

Review 9.  The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations.

Authors:  Kate V Allen; Brian M Frier; Mark W J Strachan
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

Review 10.  Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis.

Authors:  Feng-Ping Lu; Kun-Pei Lin; Hsu-Ko Kuo
Journal:  PLoS One       Date:  2009-01-07       Impact factor: 3.240

View more
  1 in total

Review 1.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.